Table 1.

Comparison between standard and alternative schedule.

		Standard schedule: recall after 3-4 weeks	Alternative schedule: priority to first dose
Doses per week		400,000 (~9.0% of cohort)
Time between doses		3–4 weeks	11 weeks
1st dose effectiveness: 0.8	Protected at 14/04	1,460,000	2,240,000 (+53.4%)
	Deaths 24/2–14/4	9,750	8,854 (−9.2%)
1st dose effectiveness: 0.6	Protected at 14/04	1,380,000	1,680,000 (+21.7%)
	Deaths 24/2–14/4	10,094	9,750 (−3.4%)
Doses per week		600,000 (~13.5% of cohort)
Time between doses		3–4 weeks	7.5 weeks
1st dose effectiveness: 0.8	Protected at 14/04	2,190,000	3,360,000 (+53.4%)
	Deaths 24/2–14/4	8,406	7,062 (−16.0%)
1st dose effectiveness: 0.6	Protected at 14/04	2,070,000	2,520,000 (+21.7%)
	Deaths 24/2–14/4	8,923	8,406 (−5.8%)
Doses per week		800.000 (~18.0% of cohort)
Time between doses		3–4 weeks	5.5 weeks
1st dose effectiveness: 0.8	Protected at 14/04	2,920,000	3,727,330 (+27.6%)
	Deaths 24/2–14/4	7,061	5,664 (−19.8%)
1st dose effectiveness: 0.6	Protected at 14/04	2,760,000	3,070,512 (+11.2%)
	Deaths 24/2–14/4	7,751	7,213 (−6.9%)